The Molinette is the main hospital of Turin's public university hospital trust, the Città della Salute e della Scienza, and works with the University of Turin. It runs care pathways for cancers from head to toe, including blood cancers, sarcomas and children's cancers.
The Presidio Ospedaliero Molinette (with the Dermatologico San Lazzaro and San Giovanni Antica Sede) is one of the hospitals of the Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, alongside the CTO, the Ospedale Infantile Regina Margherita and the Sant'Anna. The trust describes the Molinette as a multispecialty hospital integrated with the Università degli Studi di Torino, carrying out care, teaching and research within the Piedmont regional health service. Its published list of oncological diagnostic and therapeutic care pathways (PDTA) covers anal, colon, oesophageal, gastric, liver, pancreatic and biliary, gynaecological, breast, thoracic, head and neck, thyroid and endocrine, adrenal, pituitary, neurological, neuroendocrine, kidney, bladder and upper urinary tract, prostate, penile and testicular cancers, skin cancers, acute leukaemias, myelodysplasia, lymphomas, multiple myeloma, soft tissue and retroperitoneal sarcomas, bone metastases, paediatric and rare tumours, and late toxicity of cancer treatment. The trust takes part in the Rete Oncologica del Piemonte e della Valle d'Aosta, whose organisational model was approved by regional decree DGR 11-3586 of 23 July 2021.
Newsweek and Statista rank the Molinette 97th in World's Best Specialized Hospitals 2026: Oncology.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/